Section I: Basic Science of Heart Failure 1. Molecular and Cellular Mechanisms in Heart Failure including Models of Heart Failure 2. Cardiovascular Receptors and Signaling in Heart Failure 3. Inflammatory Mediators in Heart Failure 4. Epigenetics and Transcriptomics 5. Mechanisms of Hypertrophy in Heart Failure 6. Hemodynamic Adaptive Mechanisms in Heart Failure 7. Neurohormonal Axis and Natriuretic Peptides in Heart Failure 8. Biomarkers in Heart Failure 9. Mechanisms of systolic and diastolic dysfunction 10. Echocardiographic Quantitation of Ventricular Function 11. Magnetic Resonance Imaging Assessment of Heart Failure 12. Assessment of Heart Failure by Invasive Methods 13. Lymphatic System in Heart Failure 14. Endothelial Dysfunction
Section II: Clinical Diagnosis and Management of Pediatric Heart Failure 15. Epidemiology and Economic Aspects of Pediatric Heart Failure 16. Clinical Recognition of Heart Failure in Children 17. Classification of Heart Failure 18. Right Ventricular Dysfunction 19. Pediatric Myocarditis 20. Dilated Cardiomyopathy 21. Clinical Features of Restrictive Cardiomyopathy and Constrictive Pericarditis 22. Hypertrophic Cardiomyopathy 23. Left Ventricular Noncompaction 24. Arrhythmogenic Cardiomyopathies 25. Valvular Insufficiency and Heart Failure 26. Valvular Stenosis and Heart Failure 27. Coronary Artery Disease in Children and Young Adults 28. Heart Failure in Congenital Heart Disease Including Single Ventricle Circulation 29. Heart Failure in Adults with Congenital Heart Disease 30. Dysrhythmias and Ventricular Dysfunction and Heart Failure 31. Heart Failure in the Fetus 32. Heart Failure in the Neonate 33. Heart Failure in Pediatric Pulmonary Diseases 34. Cardiorenal Syndrome 35. Heart Failure in Pediatric Oncologic Disease 36. Neuromuscular Diseases 37. Sickle Cell Disease 38. The Cardiovascular System in Systemic Inflammatory Syndromes 39. Outpatient Management 40. Cardiac Intensive Care and Inpatient Management 41. Quality of Life and Psychosocial Care 42. Palliative Care 43. Quality Improvement and Learning Collaboratives 44. Nursing Aspects of Heart Failure
Section III: Medical Treatment for Pediatric Heart Failure 45. Diuretics and Invasive Fluid Management Strategies 46. Inotropic Agents in Heart Failure 47. Phosphodiesterase Inhibitors 48. Inhibition of the Renin-Angiotensin-Aldosterone System and Other Vasodilators 49. Beta-adrenergic Receptor Blockade 50. Low Cardiac Output Syndrome in the Intensive Care Setting 51. New Therapeutic Strategies in Heart Failure 52. Electrophysiologic Devices in Heart Failure 53. Catheter Device Therapy for Heart Failure
Section IV: Cardiac Surgery and Pediatric Heart Failure 54. Post-Transplant Heart Failure 55. Surgical Strategies for the Failing Systemic Ventricle 56. Valve Intervention for Valve Failure 57. General Principles of Mechanical Cardiopulmonary Support 58. Short-Term Mechanical Cardiopulmonary Support Devices 59. Decision Making in Ventricular Assist Device Support in Pediatric Patients 60. Long-Term Ventricular Assist Devices and Destination Therapy 61. Future of Mechanical Support Devices in Children and Young Adults
Section V: Special Topics 62. Genetics and Genomics 63. Genetic Testing 64. Data Management and Analytics 65. Self-Management and Outpatient Monitoring 66. Regenerative Medicine 67. Nanomedicine 68. Digital Twin and Innovation in Research Design 69. Nutritional Assessment and Management in Pediatric Heart Failure